NANJING, China, Oct. 27 /PRNewswire-Asia/ — Simcere
Pharmaceutical Group (NYSE:
SCR), a leading pharmaceutical company specializing in the
development, manufacturing, and marketing of branded generic and
proprietary pharmaceuticals in China, today announced that it will
report its unaudited financial results for the third quarter ended
September 30, 2010 on Thursday, November 11, 2010, before the
market opens in the United States. Simcere’s management will host
an earnings conference call on the same day at 8 a.m. ET (Thursday,
November 11 at 9 p.m. Beijing/Hong Kong time).To access the
conference call, please dial:United States toll-free:
+1.866.831.6291International:
+1.617.213.8860North China toll-free:
10.800.152.1490South China toll-free:
10.800.130.0399China toll free / Netcom:
10.800.852.1490Hong Kong:
+852.3002.1672Please ask to be connected to Q3 2010 Simcere
Pharmaceutical Group Earnings Conference Call and provide the
following passcode: 18468376
Simcere will also broadcast a live audio webcast of the
conference call. The broadcast will be available by visiting the
“Investor Relations” section of the company’s web site at www.simcere.com.Following the
earnings conference call, an archive of the call will be available
by dialing:United States toll-free:
+1.888.286.8010 International:
+1.617.801.6888The passcode for replay participants is:
16680817.The telephone replay also will be archived on the
“Investor Relations” section of the company’s web site for seven
days following the earnings announcement.
About Simcere Pharmaceutical GroupSimcere Pharmaceutical
Group (NYSE: SCR, Simcere) is a leading pharmaceutical company
specializing in the development, manufacturing, and marketing of
branded generic and proprietary pharmaceuticals in China. In
recent
‘/>”/>
